The University of Nevada Las Vegas Food Pantry is getting a brand new set of wheels to help assist with its food rescue efforts on campus. The new van will be used to pick up food from local grocery stores and then taken to those who utilize the food pantry services. It will also allow the food pantry to offer more quality food items to those in need.

Step out - backwards! The Chinese have a saying that 100 steps backwards are worth 1000 steps forward - and they might be onto something! It may look bizarre to onlookers, but Michael delves into the research and finds some surprising benefits. It’s been used for decades in rehabilitative physical therapy, and recent research reveals that it could even boost memory - by giving your brain a workout! Michael also speaks to biomechanics expert and champion of backwards walking, Professor Janet Dufek from the University of Nevada, Las Vegas, whose research suggests that walking backwards could help with lower back pain. They discuss why walking backwards is so beneficial for our muscles and how to do it safely.

Not only could it burn more calories, but improve your memory

The health guru was intrigued at how 'something so simple and frankly weird could have such a big effect' on our memory and problem-solving skills

During the 19th Century, the activity of "retro-walking" was little more than an eccentric hobby, but today research is revealing it can have real benefits for your health and brain.

Longeveron, a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions, reported positive top-line results from its CLEAR MIND Phase 2a human clinical trial

Neurologists at the biggest Alzheimer's research meeting in the US experienced something this week they hadn't in years: optimism.

Neurologists at the biggest Alzheimer’s research meeting in the US experienced something this week they hadn’t in years: optimism.

In 2014 neurologist Jeffrey L. Cummings, MD, startled the Alzheimer’s disease research world with a paper that laid bare the alarmingly high failure rate of Alzheimer’s disease therapies in development.

The approach even goes further, with trips to more distant areas.

The FDA was busy in September 2023, making a number of decisions on potential new therapeutic agents including granting approvals, updating a label, issuing complete response letters, granting a clearance, and lifting a clinical trial hold, among other actions.

Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced positive top-line results from its Phase 2a trial of its investigational product Lomecel-B™ for the treatment of mild Alzheimer’s disease.